154 related articles for article (PubMed ID: 30758919)
1. Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy Volunteers.
Shen Z; Lee CA; Wallach K; Valdez S; Wilson DM; Kerr B; Gillen M
Clin Pharmacol Drug Dev; 2019 Jul; 8(5):657-663. PubMed ID: 30758919
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and CYP Enzyme Substrates Sildenafil, Amlodipine, Tolbutamide, and Repaglinide.
Gillen M; Yang C; Wilson D; Valdez S; Lee C; Kerr B; Shen Z
Clin Pharmacol Drug Dev; 2017 Jul; 6(4):363-376. PubMed ID: 28067999
[TBL] [Abstract][Full Text] [Related]
3. Effects of Food and Antacids on Pharmacokinetics and Pharmacodynamics of Lesinurad, a Selective Urate Reabsorption Inhibitor.
Shen Z; Lee CA; Valdez S; Yang X; Wilson DM; Flanagan T; Gillen M
Clin Pharmacol Drug Dev; 2019 Jul; 8(5):647-656. PubMed ID: 30748125
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment.
Shen Z; Tieu K; Wilson D; Bucci G; Gillen M; Lee C; Kerr B
Clin Pharmacol Drug Dev; 2017 Jul; 6(4):377-387. PubMed ID: 28074640
[TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.
Fleischmann R; Kerr B; Yeh LT; Suster M; Shen Z; Polvent E; Hingorani V; Quart B; Manhard K; Miner JN; Baumgartner S;
Rheumatology (Oxford); 2014 Dec; 53(12):2167-74. PubMed ID: 24509406
[TBL] [Abstract][Full Text] [Related]
6. Effects of nilotinib on single-dose warfarin pharmacokinetics and pharmacodynamics: a randomized, single-blind, two-period crossover study in healthy subjects.
Yin OQ; Gallagher N; Fischer D; Zhao L; Zhou W; Leroy E; Golor G; Schran H
Clin Drug Investig; 2011; 31(3):169-79. PubMed ID: 21184622
[TBL] [Abstract][Full Text] [Related]
7. Lesinurad for the treatment of hyperuricaemia in people with gout.
Robinson PC; Dalbeth N
Expert Opin Pharmacother; 2017 Dec; 18(17):1875-1881. PubMed ID: 29103339
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers.
Yang C; Zhou D; Shen Z; Wilson DM; Renner M; Miner JN; Girardet JL; Lee CA
Drug Metab Dispos; 2019 Feb; 47(2):104-113. PubMed ID: 30442650
[TBL] [Abstract][Full Text] [Related]
9. Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.
Gillen M; Valdez S; Zhou D; Kerr B; Lee CA; Shen Z
Drug Des Devel Ther; 2016; 10():3555-3562. PubMed ID: 27843295
[TBL] [Abstract][Full Text] [Related]
10. A physiologically-based pharmacokinetic/pharmacodynamic modeling approach for drug-drug-gene interaction evaluation of S-warfarin with fluconazole.
Geng K; Shen C; Wang X; Wang X; Shao W; Wang W; Chen T; Sun H; Xie H
CPT Pharmacometrics Syst Pharmacol; 2024 May; 13(5):853-869. PubMed ID: 38487942
[TBL] [Abstract][Full Text] [Related]
11. Effect of eslicarbazepine acetate on the steady-state pharmacokinetics and pharmacodynamics of warfarin in healthy subjects during a three-stage, open-label, multiple-dose, single-period study.
Vaz-da-Silva M; Almeida L; Falcão A; Soares E; Maia J; Nunes T; Soares-da-Silva P
Clin Ther; 2010 Jan; 32(1):179-92. PubMed ID: 20171423
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, pharmacodynamics, and safety of lesinurad, a selective uric acid reabsorption inhibitor, in healthy adult males.
Shen Z; Rowlings C; Kerr B; Hingorani V; Manhard K; Quart B; Yeh LT; Storgard C
Drug Des Devel Ther; 2015; 9():3423-34. PubMed ID: 26170627
[TBL] [Abstract][Full Text] [Related]
13. Lack of a meaningful effect of anacetrapib on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.
Krishna R; Stypinski D; Ali M; Garg A; Cote J; Maes A; Degroot B; Liu Y; Li S; Connolly SM; Wagner JA; Stoch SA
Br J Clin Pharmacol; 2012 Jul; 74(1):116-24. PubMed ID: 22243494
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic re-evaluation of a genetic-guided warfarin trial.
Zambon CF; Pengo V; Moz S; Bozzato D; Fogar P; Padoan A; Plebani M; Groppa F; De Rosa G; Padrini R
Eur J Clin Pharmacol; 2018 May; 74(5):571-582. PubMed ID: 29396738
[TBL] [Abstract][Full Text] [Related]
15. Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidney.
Miner JN; Tan PK; Hyndman D; Liu S; Iverson C; Nanavati P; Hagerty DT; Manhard K; Shen Z; Girardet JL; Yeh LT; Terkeltaub R; Quart B
Arthritis Res Ther; 2016 Oct; 18(1):214. PubMed ID: 27716403
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout.
Baumgartner S; Yeh LT; Shen Z; Kerr B; Manhard K; Quart B
J Clin Pharmacol; 2018 Sep; 58(9):1164-1170. PubMed ID: 29733441
[TBL] [Abstract][Full Text] [Related]
17. In Vitro and In Vivo Interaction Studies Between Lesinurad, a Selective Urate Reabsorption Inhibitor, and Major Liver or Kidney Transporters.
Shen Z; Yeh LT; Wallach K; Zhu N; Kerr B; Gillen M
Clin Drug Investig; 2016 Jun; 36(6):443-52. PubMed ID: 26951201
[TBL] [Abstract][Full Text] [Related]
18. The effect of anastrozole on the single-dose pharmacokinetics and anticoagulant activity of warfarin in healthy volunteers.
Yates RA; Wong J; Seiberling M; Merz M; März W; Nauck M
Br J Clin Pharmacol; 2001 May; 51(5):429-35. PubMed ID: 11422000
[TBL] [Abstract][Full Text] [Related]
19. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactions.
Wittkowsky AK
Semin Vasc Med; 2003 Aug; 3(3):221-30. PubMed ID: 15199454
[TBL] [Abstract][Full Text] [Related]
20. Drug interaction studies with dexlansoprazole modified release (TAK-390MR), a proton pump inhibitor with a dual delayed-release formulation: results of four randomized, double-blind, crossover, placebo-controlled, single-centre studies.
Vakily M; Lee RD; Wu J; Gunawardhana L; Mulford D
Clin Drug Investig; 2009; 29(1):35-50. PubMed ID: 19067473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
